Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 23, Issue 6, 2011, Pages 705-713

  Cooper, Vanessa ^a   Moyle, Graeme J ^b   Fisher, Martin ^c   Reilly, Geraldine ^d   Ewan, Jacqueline ^d   Liu, Hui C ^e   Horne, Rob ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c Worthing Hospital   (United Kingdom)

^d Gilead Sciences   (United Kingdom)

^e GILEAD SCIENCES   (United States)

Author keywords

adherence; beliefs about medicines; combivir; HIV; truvada

Indexed keywords

EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS ZIDOVUDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH BELIEF; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTICENTER STUDY; OPEN STUDY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; VIRUS LOAD;

ADENINE; ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BENZOXAZINES; DEOXYCYTIDINE; DRUG COMBINATIONS; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV-1; HUMANS; LAMIVUDINE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHOSPHONIC ACIDS; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT; ZIDOVUDINE;

EID: 79956332499     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2010.534433     Document Type: Article

References (44)

1. Ammassari, A., Antinori, A., Cozzi-Lepri, A., Trotta, M.P., Nasti, G., Ridolfi, A.L.,... AdiCoNA and the LipolCoNA Study Groups. (2002). Relationship between HAART adherence and adipose tissue alterations. Journal of Acquired Immune Deficiency Syndromes, 31(3), s140-s144. (Pubitemid 35453575)
2. Bangsberg, D.R. (2006). Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral supression. Clinical Infectious Diseases, 43, 939-941. (Pubitemid 44435526)
3. Chesney, M., Ickovics, J.R., Chambers, D.B., Gifford, A.L., Neidig, J., Zwickl, B., Wu, A.W. (2000). Selfreported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12(3), 255-266. (Pubitemid 30426745)
4. Cooper, V., Gellaitry, G., Hankins, M., Fisher, M., &Horne, R. (2009). The influence of symptom experiences and attributions on adherence to highly active anti-retroviral therapy (HAART): A six-month prospective, follow-up study. AIDS Care, 21(4), 520-528.
5. Cooper, V., Horne, R., Gellaitry, G., Vrijens, B., Fisher, M., &White, D. (2010). The impact of once versus twice daily dosing and baseline beliefs about HAART on adherence to the NRTI component of efavirenzbased HAART over 48 weeks: The NOCTE study. JAIDS, 53(3), 369-377.
6. Delate, T., &Coons, S.J. (2000). The discriminative ability of the 12-item short form health survey (SF-12) in a sample of persons infected with HIV. Clinical Therapeutics, 22(9), 1112-1120.
7. El-Sadr, W.M., Grund, B., Neuhaus, J., Babiker, A., Cohen, C.J., Darbyshire, J.,... SMART Study Group. (2008). Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: A randomized trial. Annals of Internal Medicine, 149(5), 289-299.
8. Fisher, M., Moyle, G., Shahmanesh, M., Orkin, C., for the, SWEET, &(Simplification With Easier Emtricitabine Tenofovir) group, UK. (2009). A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individuals. Journal of Acquired Immune Deficiency Syndromes, 51(5), 562-568.
9. Gazzard, B.G., Anderson, J., Babiker, A., Boffito, M., Brook, G., Brough, G.,... BHIVA Treatment Guidelines Writing Group. (2008). British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Medicine, 9(8), 563-608.
10. Gifford, A.L., Bormann, J.E., Shively, M.J., Wright, B.C., Richman, D.D., &Bozzette, S.A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes JAIDS, 23(5), 386-395. (Pubitemid 30431595)
11. Gross, R., Bilker, W.B., Friedman, H.M., &Strom, B.L. (2001). Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS, 15, 2109-2117. (Pubitemid 33101818)
12. Gross, R., Yip, B., Wood, E., Bangsberg, D., Montaner, J., &Hogg, R. (2006, February 5-8). Boosted PI are more forgiving of suboptimal adherence than non-boosted PI or NNRTI. Paper presented at the 13th Conference on Retroviruses and Opportunistic Infections. Denver, Colorado.
13. Grossman, H.A., Sullivan, P.S., Wu, A.W. (2003). Quality of life and HIV: Current assessment tools and future directions for clinical practice AIDS read. 13(12). Retrieved from
14. Horne, R. (2003). Treatment perceptions and self-regulation. In L.D. Cameron &H. Leventhal (Eds.), The selfregulation of health and illness behaviour (pp. 139-153). London: Routledge.
15. Horne, R., Buick, D., Fisher, M., Leake, H., Cooper, V., &Weinman, J. (2004). Doubts about necessity and concerns about adverse effects: Identifying the types of beliefs that are associated with non-adherence to HAART. International Journal of STD and AIDS,15(1), 38-44. (Pubitemid 38096128)
16. Horne, R., Cooper, V., Gellaitry, G., Leake Date, H., &Fisher, M. (2007). Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: The utility of the necessity-concerns framework. JAIDS, 45(3), 334-341. (Pubitemid 47012382)
17. Horne, R., &Weinman, J. (1999). Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychsomatic Research, 47(6), 555-567. (Pubitemid 30029305)
18. Horne, R., &Weinman, J. (2002). Self regulation and self management in asthma: Exploring the role of illness perceptions and treatment beliefs in explaining nonadherence to preventer medication. Psychology &Health, 17(1), 17-32.
19. Horne, R., Weinman, J., Barber, N., Elliott, R.A., &Morgan, M. (2006). Concordance, adherence and compliance in medicine taking: A conceptual map and research priorities. London: National Institute for Health Research (NIHR) Service Delivery and Organisation (SDO) Programme. Retrieved from http://www.sdo.lshtm.ac.uk/sdo762004.html-o
20. Horne, R., Weinman, J., &Hankins, M. (1999). The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health, 14, 1-24.
21. Johnson, M.A., Gathe, J.C., Jr, Podzamczer, D., Molina, J.M., Naylor, C.T., King, M.S.,... Brun, S.C. (2006). A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen. Journal of Acquired Immune Deficiency Syndromes, 43(2), 153-160. (Pubitemid 44454808)
22. Kavouni, A., Catalan, J., Brown, S., Mandalia, S., &Barton, S.E. (2008). The face of HIV and AIDS: Can we erase the stigma? AIDS Care, 20(4), 485-487. (Pubitemid 351652494)
23. Liu, H., Golin, C.E., Miller, S., Hays, R.D., Beck, C.K., Sanandaji, S.,... Wenger, N. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134(10), 968-977. (Pubitemid 32466236)
24. Maggiolo, F., Ripamonti, D., Gregis, G., Quinzan, G., Callegaro, A., Arici, C.,... Suter, F. (2003). Once-a-day therapy for HIV infection: A controlled, randomized study in antiretroviral-naive HIV-1-infected patients. Antiviral Therapy, 8(4), 339-346. (Pubitemid 37101638)
25. Maitland, D., Jackson, A., Osorio, J., Mandalia, S., Gazzard, B.G., &Moyle, G.J. (2008). Switching from twice-daily abacavir and lamivudine to the once-daily fixed-dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy. HIV Medicine, 9(8), 667-672.
26. Mannheimer, S.B., Matts, J., Telzak, E., Chesney, M., Child, C., Wu, A.W.,... Terry Beirn Community Programs for Clinical Research on AIDS. (2005). Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care, 17(1), 10-22. (Pubitemid 40175528)
27. McNabb, J., Ross, J.W., Abriola, K., Turley, C., Nightingale, C.H., &Nicolau, D.P. (2001). Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. 33(5), 700-705.
28. Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., d'Arminio Monforte, A.,... EuroSIDA Study Group. (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362(9377), 22-29. (Pubitemid 36835816)
29. Molassiotis, A., Nahas-Lopez, V., Chung, W.Y., Lam, S.W., Li, C.K., &Lau, T.F. (2002). Factors associated with adherence to antiretroviral medication in HIVinfected patients. International Journal of STD &AIDS, 13(5), 301-310. (Pubitemid 34492965)
30. Molina, J.M., Journot, V., Furco A., Palmer, P., De Castro, N., Raffi, F.,... Montana (ANRS 091) Study Group. (2007). Five-year follow-up of once daily HAART with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial). Antiviral Therapy, 12(3), 417-422.
31. Moyle, G. (2003). The Assessing Patients' Preferred Treatments (APPT-1) study. International Journal of STD and AIDS, 14(Suppl 1), 34-36. (Pubitemid 37352579)
32. Newell, A., Mendes, S., &Horne, R. (2002). Assessing the psychological and therapy-related barriers to optimal adherence: An observational study. Paper presented at the sixth international congress on Drug Therapy in HIV Infection, November, Glasgow, UK.
33. Palella, F., Delaney, K., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A.,... Holmberg, S.D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853-860. (Pubitemid 28135961)
34. Parienti, J.J., Bangsberg, D.R., Verdon, R., &Gardner, E.M. (2009). Better adherence with once-daily antiretroviral regimens: A meta-analysis. Clinical Infectious Diseases, 48(4), 484-488.
35. Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., Squier, C.,... Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21-30. (Pubitemid 30432540)
36. Rajagopalan, R., Laitinen, D., &Dietz, B. (2008). Impact of lipoatrophy on quality of life in HIV patients receiving anti-retroviral therapy. AIDS Care, 20(10), 1197-1201.
37. Santos, J., Palacios, R., López, M., Gálvez, M.C., Lozano, F., de la Torre, J.,... Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. (2005). Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: The VESD study. HIV Clinical Trials, 6(6), 320-328. (Pubitemid 43336966)
38. Spire, B., Duran, S., Souville, M., Leport, C., &Raffi, F. (2002). Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach. Social Science and Medicine, 54, 1481-1496. (Pubitemid 34309013)
39. Sterne, J.A., Hernan, M.A., Ledergerber, B., Tilling, K., Weber, R., Sendi, P.,... Swiss HIV Cohort Study. (2005). Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: A prospective cohort study. Lancet, 366(9483), 378-384. (Pubitemid 41073955)
40. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. (2006). CD4-Count- Guided Interruption of Antiretroviral Treatment. New England Journal of Medicine, 355, 2283-2296.
41. Viswanathan, H, Anderson, R., &Thomas Joseph, III. (2005). Nature and correlates of SF-12 physical and mental quality of life components among low-income HIV adults using an HIV service center. Quality of Life Research, 14, 935-944. (Pubitemid 40685218)
42. Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., &Burnier, M. (2008). Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. British Medical Journal, 336(7653), 1114-1117. (Pubitemid 351731741)
43. Walsh, J.C., Mandalia, S., &Gazzard, B.G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS, 16(2), 269-277. (Pubitemid 34118574)
44. Ware, J.J., Kosinski, M., &Keller, S.D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220-233. (Pubitemid 126433231)